Agilon Health (AGL) Receivables - Other (2020 - 2023)

Agilon Health has reported Receivables - Other for 4 years, with the latest figure at $4.6 million in Q4 2023.

• For the quarter ending Q4 2023, Receivables - Other fell 33.33% year-over-year to $4.6 million; the trailing twelve-month figure through Dec 2023 stood at $4.6 million (down 33.33% YoY), and the FY2023 full-year result was $4.6 million, down 33.33% from the prior year.
• Receivables - Other for Q4 2023 stood at $4.6 million, down from $6.9 million in the prior quarter.
• The five-year high for Receivables - Other was $10.2 million in Q3 2021, with the low at $500000.0 in Q4 2021.
• Historically, Receivables - Other has averaged $6.4 million across 4 years, with a median of $6.9 million in 2022.
• Annual changes were most pronounced in 2021 — Receivables - Other slumped 95.0% — and 2022, when it surged 1280.0%.
• Agilon Health's Receivables - Other stood at $10.0 million in 2020, then tumbled by 95.0% to $500000.0 in 2021, then surged by 1280.0% to $6.9 million in 2022, then plunged by 33.33% to $4.6 million in 2023.
• The last three Receivables - Other figures came in at $4.6 million (Q4 2023), $6.9 million (Q4 2022), and $500000.0 (Q4 2021), per Business Quant data.